FESZ showed overall progressive reductions in 40-Hz ASSR PLF and progressive increases in induced gamma power, especially within the left auditory cortex. These progressive deficits were not related to antipsychotic medication. Progressive increase of induced gamma power was correlated with increased positive symptoms. Discussion: We found coincide disruptions of auditory gamma-band oscillation, which showed progressive increase in spontaneous gamma (cortical excitability) and progressive decrease in synchrony gamma (cortical synchrony failure) during continuous auditory stimuli in FESZ. These two apparently distinctive circuit progressive abnormalities already occurred in the very early stage of the disease. We propose that assessing ASSR-PLF and spontaneous gamma in FESZ may provide a sensitive translatable biomarker for the integrity of neural networks that are fundamentally altered in the very early stage of SZ. Background: Although there is a cumulative evidence for increased level of markers of inflammation in psychosis, it has not been conclusively proven yet whether this is due to the disorder in itself or to other factors. One reason for this is the lack of studies that have controlled for major confounding factors such as obesity, smoking, antipsychotic use and stress. The BMI, as an indirect measure of body fat level, and tobacco smoking are known to play a role in modulating the immune system, but little research has been done in this area in patients with psychosis. The aim of this study was to investigate the differences in markers of inflammation and neuroplasticity between FEP patients and HC while controlling for a priori confounding factors, such as BMI and tobacco smoking. Methods: Nineteen First Episode Psychosis (FEP) patients and 21 healthy controls (HC) matched for age, gender, ethnicity and marital status were recruited in South London (UK). Blood samples were collected to measure High Sensitivity C-Reactive Protein (hs-CRP), Interleukin (IL)-6, IL-8 and Brain-Derived Neurotrophic Factor (BDNF). Body Mass Index (BMI) was also assessed. Moreover, patients were asked whether they were tobacco smokers. Differences in continuous variables were analysed using independent samples t-tests. Categorical variables were assessed using the chi-square (χ2) test. One-way ANCOVAs were conducted to assess difference between FEP patients and HC in markers of inflammation and BDNF while controlling for the effect of BMI and tobacco smoking. All analyses were conducted using IBM SPSS statistical software version 23. The significance value for all tests was set at α = 0.05. Results: FEP patients had higher serum level of hs-CRP compared to controls (N = 19, M = 2.29 mg/L, SD = 2.76; N = 21, M = 0.56 mg/L, SD = 0.41; respectively, t(27.79)=-2.41, p=0.02), suggestive of a hyperactivation of the immune system. There was no significant difference in IL-6, IL-8 and BDNF serum levels between the two groups. BMI was significantly higher in patients than controls (N = 19, M = 27.67, SD = 4.91; N = 21, M = 23.55, SD = 3.31; respectively, t(38)=-3.14, p=0.003) and there was a significantly higher number of smokers in the FEP patient group than in the HC group (smokers= 57.9% of FEP patients; smokers=14.3% of HC; χ2(1)=8.34, p=0.004). The one-way ANCOVAs showed that there was not significant effect of group on hs-CRP, IL-6, IL-8 and BDNF values when controlling for BMI and tobacco smoking. In fact, BMI was significantly related to the hs-CRP level, F(1,36) = 7.20, p = 0.01.
Discussion: We found that BMI and tobacco smoking may be important confounding factors when investigating disease-related alterations in the levels of hs-CRP, IL-6, IL-8 and BDNF. More studies are needed to assess the role of potential confounding factors on markers of inflammation in psychosis and to understand the role of immune activation in the pathophysiology of these disorders. 
T15. LONGITUDINAL ASSOCIATIONS BETWEEN CHILDHOOD SALIVARY CORTISOL LEVELS AND PRODROMAL SYMPTOMS IN LATE ADOLESCENCE: FINDINGS FROM A HIGH-RISK COHORT

Australian Catholic University
Background: Individuals with established psychosis are characterised by a distinct pattern of hypothalamic-pituitary-adrenal (HPA) axis dysfunctions which include both elevated daytime cortisol levels and a blunted cortisol awakening response (CAR). Whilst these patterns of dysfunction have also been observed among those at elevated risk for the disorder, longitudinal studies are scarce. As such, the relevance of these HPA axis abnormalities for the progression of psychopathology in high-risk populations is unknown. Utilising data from a well-characterised, longitudinal cohort of youth at elevated risk for schizophrenia and their typically-developing peers (The Child Health and Development Study), we aimed to investigate the extent to which HPA axis function determined in childhood is a significant predictor of putative prodromal status and psychopathology in late adolescence/early adulthood. Methods: The sample comprised high-risk individuals who presented either multiple antecedents of schizophrenia (developmental delays, psychopathology, and psychotic-like experiences: ASz=21) or a family history of illness (FHx=13), and typically-developing youth with neither antecedents nor a family history (TD=36). Participants were recruited at age 9-12 years using a community screening method and assessed biennially throughout adolescence. At the age 11-14 years assessment phase, participants collected salivary cortisol samples in their home environment which were used to determine diurnal cortisol secretion and the CAR. At the age 17-21 years assessment phase, participants completed measures of prodromal symptoms (Prodromal Questionnaire: PQ), depression (Quick Inventory of Depressive Symptomatology questionnaire: QIDS), and anxiety (Social Interaction Anxiety Scale: SIAS). Established PQ thresholds were used to identify participants who met probable prodromal status. Logistic and linear regression analyses were used to examine the extent to which salivary cortisol measures at age 11-14 years predicted probable prodromal status and continuous psychopathology measures at 17-21 years, respectively. Results: Relative to the TD group, ASz youth were characterised by higher depression (B=0.24, p=0.05) and disorganised symptoms (B=0.36, p=0.007) at 17-21 years whilst FHx youth obtained higher scores on the PQ general symptoms scale (B=0.24, p=0.048). Analyses performed in the total sample indicated that the CAR was negatively associated with depression symptoms (B=-0.28, p=0.006) and PQ negative symptoms (B=-0.30, p=0.004) at age 17-21 years. Positive associations were observed between diurnal cortisol and positive (B=0.41, p=0.02), disorganised (B=0.30, p=0.04), and general (B=0.29, p=0.03) PQ symptoms. Diurnal cortisol levels were also significantly associated with probable prodromal status at follow-up (OR=1.04, p=0.04). No significant interactions were observed between group status and salivary cortisol levels in any model. After adjustment for potential confounders (age, follow-up time, sex, BMI, and pubertal status), the CAR continued to show significant associations with both depression (p=0.006) and PQ negative symptoms (p=0.007) whilst only a statistical trend was observed for the relationship between diurnal cortisol levels and positive symptoms (p=0.055). Discussion: The current study is the first to examine the extent to which HPA axis function can predict development of prodromal symptoms in a high-risk cohort. Our finding that more abnormal HPA axis function (i.e., a decreased CAR and higher diurnal cortisol) at age 11-14 years is associated with both prodromal and depression symptoms at age 17-21 has important implications for aetiological theories and for clinical practice. 
T16. GLUTAMATERGIC CHANGES IN UHR
The search for biomarkers may prove significant for shortterm identification of UHR individuals (remission/non-remission). On a long-term basis, biomarkers might give the opportunity to delay or prevent psychotic episodes. Disturbances of the neurotransmitters glutamate and GABA have long been suspected to be involved in the pathophysiology of psychosis. These disorders have also found been found in people at UHR, making it a promising area for early detection. Cognitive deficits in schizophrenia are present prior to the onset of psychosis, and may be linked to perturbed glutamate and GABA function. Data suggest that this link is already present in UHR states. Results: So far 116 UHR individuals and 42 healthy controls have been scanned (December 2017) Very early preliminary analysis of the baseline data finds no significant difference in glutamate levels (in ACC and thalamus) in UHR patients compared to matched healthy controls. Baseline data remains to be analysed in relation to relevant subgroups of patients e.g. based on clinical outcome. GABA analysis and analysis of follow-up data are also yet to be performed. Data will be ready for the meeting, and will be presented. Discussion: More studies are needed in this field, since results so far have been diverging. Baseline data remains to be analysed in relation to relevant subgroups of patients e.g. based on clinical outcome. GABA analysis and analysis of follow-up data are also yet to be performed. Glutamate data will be presented at the meeting. Discussion: Lower concentrations of LPO were related to greater severity of negative symptoms as avolition and blunted affect (inner world). Longitudinal analyses showed that higher % of hemolysis at baseline predict an improvement of negative dimension at 1-year follow-up. From our results, we hypothesize that there is an inverse relationship between oxidative stress and negative dimension in stable patients with schizophrenia during the first ten years of illness. Background: In schizotypy, a factor structure similar to the one observed in schizophrenia has been unraveled, being the positive and negative the most consistently replicated dimensions. Despite this fact, most of the studies on brain volume patterns in schizotypy consider it as an unitary rather than a multidimensional construct. Hence, based on previous results showing that schizophrenia and schizotypal personality traits share common
T17. OXIDATIVE STRESS BIOMARKERS AND
